® Differin (adapalene) Gel, 0.1% For the treatment of acne Nonprescription Drugs Advisory Committee April 15, 2016 CC-1 ® Differin (adapalene) Gel, 0.1% Howard Marsh, MD Vice President, Medical Affairs Galderma CC-2 Acne is a Common and Chronic Condition Affects more than 85% of teenagers but can occur in most age groups Frequently persists into adulthood Chronic and recurring condition 70% of acne sufferers don’t consult their doctor ZaengleinAL, et al. J Am AcadDermatol. 2016:http://dx.doi.org/10.1016/j.jaad.2015.12.037. Nielsen Research Survey of Acne Sufferers. 2015. CC-3 Acne is Highly Visible CC-4 Acne Has High Psychological Burden Acne sufferers can feel: Self-conscious Depressed A lack of confidence Embarrassment and shame Socially isolated or withdrawn HalvorsenJA, et al. J Invest Dermatol.2011;131:363-370 Alexis A, et al. J Drugs Dermatol. 2014;13:330-340. UhlenhakeE, et al. J CosmetDermatol.2010;9:59-63. CC-5 Acne is an OTC Condition Five active ingredients are allowed for nonprescription use under the Monograph system Benzoyl peroxide and salicylic acid make up 99% of the OTC acne drug market Others include sulfur, resorcinol and resorcinol monoacetate No new OTC acne active ingredients since the 1980s CC-6 What is Adapalene? A new chemical entity discovered by Galderma in 1984 A third generation retinoid designed to be stable in the presence of light and oxygen Anti-inflammatory and inhibits comedo formation CC-7 Czernielewski J, et al. J EurAcadDermatolVenerol.2001;15:S5-12. Seven FDA Approved Adapalene Formulations Differin (adapalene) Gel, 0.1% was approved in 1996 Approved in 4 other dosage forms and strengths: 0.1% cream, lotion and solution 0.3% gel Approved in 2 combination products: Adapalene 0.1% and 0.3% in combination with benzoyl peroxide 2.5% CC-8 Differin Gel Meets General Criteria for OTC Drugs The consumer must be able to self-diagnose the condition to be treated The consumer must be able to read and understand the product labeling to ensure proper usage The product must be effective when used as recommended The drug must be safe for self-use CC-9 Consumers Can Self-Diagnose and Self-Treat Acne Self-diagnosed and self-treated by consumers for decades Topical acne drugs are currently marketed OTC and have been for decades CC-10
Description: